People_

Dr Jie-Bin Lew

Research Fellow
Sydney School of Public Health
Faculty of Medicine and Health
Gastrointestinal Cancers Policy and Evaluation Stream
The Daffodil Centre

Email

jiebin.lew@sydney.edu.au

Websites

The Daffodil Centre

Biographical details

Dr Jie-Bin Lew is a researcher of Gastrointestinal Cancers Group. Her research focuses on optimising colorectal cancer screening subgroup in Australia and other countries. Jie-Bin led the development of a comprehensive microsimulation model of colorectal cancer natural history and screening in Australia (Policy1-Bowel). This model has been applied to several evaluations on important bowel cancer screening policy questions in Australia. Findings from these evaluations were used to support colorectal cancer screening guidelines recommendations and government funding decision in Australia. She has been awarded the Investigator Grant by National Health and Medical Research Council in 2020 to evaluate colorectal cancer screening approaches in high-income countries and low-and-middle income countries.

Research interests

Gastrointestinal Cancers, Screening

Publications

By Type

Expand all

Journals

Li, Y., Shi, J., Wang, X., Wu, Y., Zhou, X., Li, J., Qin, J., Xu, W., Lew, J., Chen, W. (2024). Access to colorectal cancer screening in populations in China, 2020: A coverage-focused synthesis analysis. International Journal of Cancer, 155(3), 558-568. [More Information]
Wang, H., Li, Y., Lei, L., Liu, C., Chen, W., Dai, M., Wang, X., Lew, J., Shi, J., Li, N., et al (2024). Estimating the economic burden of colorectal cancer in China, 2019–2030: A population-level prevalence-based analysis. Cancer Medicine, 13(1). [More Information]
Nickson, C., Smith, M., Feletto, E., Velentzis, L., Broun, K., Deij, S., Grogan, P., Hall, M., He, E., St John, D., Lew, J., Procopio, P., Simms, K., Worthington, J., Canfell, K., et al (2023). A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia. eLife, 12. [More Information]
Yap, S., He, E., Egger, S., Goldsbury, D., Lew, J., Ngo, P., Worthington, J., Rillstone, H., Zalcberg, J., Cuff, J., Ward, R., Canfell, K., Feletto, E., Steinberg, J. (2023). Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort. BMC Cancer, 23(1). [More Information]
Worthington, J., He, E., Lew, J., St John, J., Horn, C., Grogan, P., Canfell, K., Feletto, E. (2023). Colonoscopies in Australia - how much does the National Bowel Cancer Screening Program contribute to colonoscopy use? Public Health Research and Practice, 33(1). [More Information]
Worthington, J., van Wifferen, F., Sun, Z., de Jonge, L., Lew, J., Greuter, M., van den Puttelaar, R., Feletto, E., Lansdorp-Vogelaar, I., Coupé, V., Canfell, K., et al (2023). Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening. EClinicalMedicine, 62. [More Information]
Worthington, J., Lew, J., He, E., Broun, K., D'Onise, K., Grogan, P., Canfell, K., Feletto, E. (2023). The 'hot zone policy' for colorectal cancer screening presents unique risks and opportunities for rural Australia. Australian Journal of Rural Health. [More Information]
Lew, J., Feletto, E., Worthington, J., Roder, D., Canuto, K., Miller, C., D'Onise, K., Canfell, K. (2022). The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study. Journal of Cancer Policy, 32, 100325-1-100325-11. [More Information]
Luo, Q., Lew, J., Steinberg, J., Worthington, J., Yu, X., Caruana, M., Soerjomataram, I., Bray, F., Lawrance, S., Arcorace, M., O'Connell, D., Canfell, K., Feletto, E. (2022). Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040. Scientific Reports, 12(1), 3994. [More Information]
Shi, J., Wang, L., Ran, J., Wang, H., Liu, C., Zhang, H., Yang, L., Shi, S., Jiang, L., et al, et al (2021). Clinical characteristics and medical service utilization of lung cancer in China, 2005 - 2014: Overall design and results from a multicenter retrospective epidemiologic survey. Cancer, 127(11), 1880-1893. [More Information]
Smith, M., Hall, M., Saville, M., Brotherton, J., Simms, K., Lew, J., Bateson, D., Skinner, R., Kelaher, M., Canfell, K. (2021). Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiology Biomarkers and Prevention, 30(2), 268-277. [More Information]
Keane, A., Shi, J., Simms, K., Liu, Y., Lew, J., Mazariego, C., Yuill, S., Wu, R., Liu, Z., Zhao, F., Canfell, K., et al (2021). Health economic evaluation of primary human papillomavirus screening in urban populations in China. Cancer Epidemiology, 70, 101861. [More Information]
Goldsbury, D., Feletto, E., Weber, M., Haywood, P., Pearce, A., Lew, J., Worthington, J., He, E., Steinberg, J., O'Connell, D., Canfell, K. (2021). Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia. PloS One, 16(11-Nov), e0260088. [More Information]
de Jonge, L., Worthington, J., van Wifferen, F., Iragorri, N., Peterse, E., Lew, J., Greuter, M., Smith, H., Feletto, E., Yong, J., Canfell, K., et al (2021). Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. The Lancet Gastroenterology & Hepatology, 6(4), 304-314. [More Information]
van Wifferen, F., de Jonge, L., Worthington, J., Greuter, M., Lew, J., Nadeau, C., van den Puttelaar, R., Feletto, E., Yong, J., Lansdorp-Vogelaar, I., Canfell, K., et al (2021). Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study. Journal of Medical Screening. [More Information]
Worthington, J., Feletto, E., Lew, J., Broun, K., Durkin, S., Wakefield, M., Grogan, P., Harper, T., Canfell, K. (2020). Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia. Public Health, 179, 90-99. [More Information]
Worthington, J., Lew, J., Feletto, E., Holden, C., Worthley, D., Miller, C., Canfell, K. (2020). Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment. PloS One, 15(2), 1-15. [More Information]
Feletto, E., Lew, J., Worthington, J., He, E., Caruana, M., Butler, K., Hui, H., Taylor, N., Banks, E., Barclay, K., Grogan, P., Kench, J., Taoube, L., Ward, R., Armstrong, B., Canfell, K., et al (2020). Pathways to a cancer-free future: A protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia. BMJ Open, 10(6), 1-9. [More Information]
Lew, J., Greuter, M., Caruana, M., He, E., Worthington, J., St John, D., Macrae, F., Feletto, E., Coupe, V., Canfell, K. (2020). Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Medical Decision Making, 40(6), 815-829. [More Information]
Lew, J., Feletto, E., Wade, S., Caruana, M., Kang, Y., Nickson, C., Simms, K., Procopio, P., Taylor, N., Worthington, J., Smith, D., Canfell, K. (2019). Benefits, harms and cost-effectiveness of cancer screening in Australia: An overview of modelling estimates. Public Health Research and Practice, 29(2), 1-11. [More Information]
Liu, Y., Keane, A., Simms, K., Lew, J., Shi, J., Mazariego, C., Yuill, S., Jeronimo, J., Qiao, Y., Canfell, K. (2019). Development and application of a framework to estimate health care costs in China: The cervical cancer example. PloS One, 14(10), 1-13. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology, 20(3), 394-407. [More Information]
Velentzis, L., Smith, M., Simms, K., Lew, J., Hall, M., Hughes, S., Yuill, S., Killen, J., Keane, A., Butler, K., Skinner, R., Brand, A., Bateson, D., Armstrong, B., Canfell, K., et al (2019). Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. Gynecologic Oncology, 152(3), 465-471. [More Information]
Hall, M., Smith, M., Lew, J., O'Hallahan, J., Fentiman, G., Neal, H., Sage, M., Canfell, K. (2019). The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications. Gynecologic Oncology, 152(3), 472-479. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Brotherton, J., Saville, M., Frazer, I., Canfell, K. (2019). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health, 4(1), e19-e27. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Towards global elimination of cervical cancer in all groups of women - Authors' reply. The Lancet Oncology, 20(5), e239. [More Information]
Feletto, E., Yu, X., Lew, J., St John, D., Jenkins, M., Macrae, F., Mahady, S., Canfell, K. (2019). Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases. Cancer Epidemiology Biomarkers and Prevention, 28(1), 83-90. [More Information]
Lew, J., St John, D., Macrae, F., Emery, J., Ee, H., Jenkins, M., He, E., Grogan, P., Caruana, M., Greuter, M., Canfell, K., et al (2018). Benefits, harms and cost-effectiveness of potential age-extensions to the National Bowel Cancer Screening Program in Australia. Cancer Epidemiology Biomarkers and Prevention, 27(12), 1450-1461. [More Information]
Lew, J., St John, D., Macrae, F., Emery, J., Ee, H., Jenkins, M., He, E., Grogan, P., Caruana, M., Sarfati, D., Canfell, K., et al (2018). Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia. International Journal of Cancer, 143(2), 269-282. [More Information]
He, E., Lew, J., Egger, S., Banks, E., Ward, R., Beral, V., Canfell, K. (2018). Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort. Preventive Medicine, 106, 185-193. [More Information]
Smith, M., Hall, M., Lew, J., Canfell, K. (2018). Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand. Vaccine, 36(42), 6314-6324. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]
Lew, J., Simms, K., Smith, M., Saville, M., Hammond, I., Canfell, K. (2017). Cost-effectiveness estimates: the need for complete reporting – Authors' reply. The Lancet Public Health, 2(5), e212. [More Information]
Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
Lew, J., St John, D., Xu, X., Greuter, M., Caruana, M., Cenin, D., He, E., Saville, A., Grogan, P., Coupe, V., Canfell, K. (2017). Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: A modelling study. The Lancet Public Health, 2(7), e331-e340. [More Information]
Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]
Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
Greuter, M., Demirel, E., Lew, J., Berkhof, J., Xu, X., Canfell, K., Dekker, E., Meijer, G., Coupé, V. (2016). Long-term impact of the dutch colorectal cancer screening program on cancer incidence and mortality - Model-based exploration of the serrated pathway. Cancer Epidemiology Biomarkers and Prevention, 25(1), 135-144. [More Information]
Greuter, M., Berkhof, J., Canfell, K., Lew, J., Dekker, E., Coupe, V. (2016). Resilience of a FIT screening programme against screening fatigue: a modelling study. BMC Public Health, 16(1), 1-8. [More Information]
Greuter, M., Berkhof, J., Fijneman, R., Demirel, E., Lew, J., Meijer, G., Stoker, J., Cou?e, V. (2016). The potential of imaging techniques as a screening tool for colorectal cancer: A cost-effectiveness analysis. British Journal of Radiology, 89(1063), 20150910. [More Information]
Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]
Simms, K., Smith, M., Lew, J., Kitchener, H., Castle, P., Canfell, K. (2016). Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. International Journal of Cancer, 139(12), 2771-2780. [More Information]
Kang, Y., O'Connell, D., Tan, J., Lew, J., Demers, A., Lotocki, R., Kliewer, E., Hacker, N., Jackson, M., Delaney, G., et al (2015). Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. Cancer Epidemiology, 39(4), 600-611. [More Information]
Greuter, M., Xu, X., Lew, J., Dekker, E., Kuipers, E., Canfell, K., Meijer, G., Coupé, V. (2014). Modeling the adenoma and serrated pathway to colorectal cancer (ASCCA). Risk Analysis, 34(5), 889-910. [More Information]
Walker, R., Nickson, C., Lew, J., Smith, M., Canfell, K. (2012). A revision of sexual mixing matrices in models of sexually transmitted infection. Statistics in Medicine, 31(27), 3419-3432. [More Information]
Legood, R., Smith, M., Lew, J., Walker, R., Moss, S., Kitchener, H., Patnick, J., Canfell, K. (2012). Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ: British Medical Journal, 345, 1-10. [More Information]
Shi, J., Chen, J., Canfell, K., Feng, X., Ma, J., Zhang, Y., Zhao, F., Li, R., Ma, L., Li, Z., et al (2012). Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study. BMC Health Services Research, 12(1), 1-14. [More Information]
Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]
Shi, J., Canfell, K., Lew, J., Qiao, Y. (2012). The burden of cervical cancer in China: Synthesis of the evidence. International Journal of Cancer, 130(3), 641-652. [More Information]
Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]
Canfell, K., Shi, J., Lew, J., Walker, R., Zhoa, F., Simonella, L., Chen, J., Legood, R., Smith, M., Nickson, C., et al (2011). Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Vaccine, 29(13), 2487-2494. [More Information]
Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]
Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]
Beekman, M., Lew, J. (2008). Foraging in honeybees - when does it pay to dance? Behavioral Ecology, 19(2), 255-262. [More Information]
Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]
Ho, J., Adams, C., Lew, J., Matthews, T., Ng, C., Shahabi-Sirjani, A., Tan, L., Zhao, C., Easteal, S., Wilson, S., Jermiin, L. (2006). SeqVis: Visualisation of compositional heterogeneity in large alignments of nucleotides. Bioinformatics, 22(17), 2162-2163. [More Information]

show 56 more

By Year

Expand all

2024

Li, Y., Shi, J., Wang, X., Wu, Y., Zhou, X., Li, J., Qin, J., Xu, W., Lew, J., Chen, W. (2024). Access to colorectal cancer screening in populations in China, 2020: A coverage-focused synthesis analysis. International Journal of Cancer, 155(3), 558-568. [More Information]
Wang, H., Li, Y., Lei, L., Liu, C., Chen, W., Dai, M., Wang, X., Lew, J., Shi, J., Li, N., et al (2024). Estimating the economic burden of colorectal cancer in China, 2019–2030: A population-level prevalence-based analysis. Cancer Medicine, 13(1). [More Information]

2023

Nickson, C., Smith, M., Feletto, E., Velentzis, L., Broun, K., Deij, S., Grogan, P., Hall, M., He, E., St John, D., Lew, J., Procopio, P., Simms, K., Worthington, J., Canfell, K., et al (2023). A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia. eLife, 12. [More Information]
Yap, S., He, E., Egger, S., Goldsbury, D., Lew, J., Ngo, P., Worthington, J., Rillstone, H., Zalcberg, J., Cuff, J., Ward, R., Canfell, K., Feletto, E., Steinberg, J. (2023). Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort. BMC Cancer, 23(1). [More Information]
Worthington, J., He, E., Lew, J., St John, J., Horn, C., Grogan, P., Canfell, K., Feletto, E. (2023). Colonoscopies in Australia - how much does the National Bowel Cancer Screening Program contribute to colonoscopy use? Public Health Research and Practice, 33(1). [More Information]
Worthington, J., van Wifferen, F., Sun, Z., de Jonge, L., Lew, J., Greuter, M., van den Puttelaar, R., Feletto, E., Lansdorp-Vogelaar, I., Coupé, V., Canfell, K., et al (2023). Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening. EClinicalMedicine, 62. [More Information]
Worthington, J., Lew, J., He, E., Broun, K., D'Onise, K., Grogan, P., Canfell, K., Feletto, E. (2023). The 'hot zone policy' for colorectal cancer screening presents unique risks and opportunities for rural Australia. Australian Journal of Rural Health. [More Information]

show 2 more

2022

Lew, J., Feletto, E., Worthington, J., Roder, D., Canuto, K., Miller, C., D'Onise, K., Canfell, K. (2022). The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study. Journal of Cancer Policy, 32, 100325-1-100325-11. [More Information]
Luo, Q., Lew, J., Steinberg, J., Worthington, J., Yu, X., Caruana, M., Soerjomataram, I., Bray, F., Lawrance, S., Arcorace, M., O'Connell, D., Canfell, K., Feletto, E. (2022). Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040. Scientific Reports, 12(1), 3994. [More Information]

2021

Shi, J., Wang, L., Ran, J., Wang, H., Liu, C., Zhang, H., Yang, L., Shi, S., Jiang, L., et al, et al (2021). Clinical characteristics and medical service utilization of lung cancer in China, 2005 - 2014: Overall design and results from a multicenter retrospective epidemiologic survey. Cancer, 127(11), 1880-1893. [More Information]
Smith, M., Hall, M., Saville, M., Brotherton, J., Simms, K., Lew, J., Bateson, D., Skinner, R., Kelaher, M., Canfell, K. (2021). Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiology Biomarkers and Prevention, 30(2), 268-277. [More Information]
Keane, A., Shi, J., Simms, K., Liu, Y., Lew, J., Mazariego, C., Yuill, S., Wu, R., Liu, Z., Zhao, F., Canfell, K., et al (2021). Health economic evaluation of primary human papillomavirus screening in urban populations in China. Cancer Epidemiology, 70, 101861. [More Information]
Goldsbury, D., Feletto, E., Weber, M., Haywood, P., Pearce, A., Lew, J., Worthington, J., He, E., Steinberg, J., O'Connell, D., Canfell, K. (2021). Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia. PloS One, 16(11-Nov), e0260088. [More Information]
de Jonge, L., Worthington, J., van Wifferen, F., Iragorri, N., Peterse, E., Lew, J., Greuter, M., Smith, H., Feletto, E., Yong, J., Canfell, K., et al (2021). Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. The Lancet Gastroenterology & Hepatology, 6(4), 304-314. [More Information]
van Wifferen, F., de Jonge, L., Worthington, J., Greuter, M., Lew, J., Nadeau, C., van den Puttelaar, R., Feletto, E., Yong, J., Lansdorp-Vogelaar, I., Canfell, K., et al (2021). Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study. Journal of Medical Screening. [More Information]

show 3 more

2020

Worthington, J., Feletto, E., Lew, J., Broun, K., Durkin, S., Wakefield, M., Grogan, P., Harper, T., Canfell, K. (2020). Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia. Public Health, 179, 90-99. [More Information]
Worthington, J., Lew, J., Feletto, E., Holden, C., Worthley, D., Miller, C., Canfell, K. (2020). Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment. PloS One, 15(2), 1-15. [More Information]
Feletto, E., Lew, J., Worthington, J., He, E., Caruana, M., Butler, K., Hui, H., Taylor, N., Banks, E., Barclay, K., Grogan, P., Kench, J., Taoube, L., Ward, R., Armstrong, B., Canfell, K., et al (2020). Pathways to a cancer-free future: A protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia. BMJ Open, 10(6), 1-9. [More Information]
Lew, J., Greuter, M., Caruana, M., He, E., Worthington, J., St John, D., Macrae, F., Feletto, E., Coupe, V., Canfell, K. (2020). Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Medical Decision Making, 40(6), 815-829. [More Information]

show 1 more

2019

Lew, J., Feletto, E., Wade, S., Caruana, M., Kang, Y., Nickson, C., Simms, K., Procopio, P., Taylor, N., Worthington, J., Smith, D., Canfell, K. (2019). Benefits, harms and cost-effectiveness of cancer screening in Australia: An overview of modelling estimates. Public Health Research and Practice, 29(2), 1-11. [More Information]
Liu, Y., Keane, A., Simms, K., Lew, J., Shi, J., Mazariego, C., Yuill, S., Jeronimo, J., Qiao, Y., Canfell, K. (2019). Development and application of a framework to estimate health care costs in China: The cervical cancer example. PloS One, 14(10), 1-13. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology, 20(3), 394-407. [More Information]
Velentzis, L., Smith, M., Simms, K., Lew, J., Hall, M., Hughes, S., Yuill, S., Killen, J., Keane, A., Butler, K., Skinner, R., Brand, A., Bateson, D., Armstrong, B., Canfell, K., et al (2019). Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. Gynecologic Oncology, 152(3), 465-471. [More Information]
Hall, M., Smith, M., Lew, J., O'Hallahan, J., Fentiman, G., Neal, H., Sage, M., Canfell, K. (2019). The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications. Gynecologic Oncology, 152(3), 472-479. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Brotherton, J., Saville, M., Frazer, I., Canfell, K. (2019). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health, 4(1), e19-e27. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Towards global elimination of cervical cancer in all groups of women - Authors' reply. The Lancet Oncology, 20(5), e239. [More Information]
Feletto, E., Yu, X., Lew, J., St John, D., Jenkins, M., Macrae, F., Mahady, S., Canfell, K. (2019). Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases. Cancer Epidemiology Biomarkers and Prevention, 28(1), 83-90. [More Information]

show 5 more

2018

Lew, J., St John, D., Macrae, F., Emery, J., Ee, H., Jenkins, M., He, E., Grogan, P., Caruana, M., Greuter, M., Canfell, K., et al (2018). Benefits, harms and cost-effectiveness of potential age-extensions to the National Bowel Cancer Screening Program in Australia. Cancer Epidemiology Biomarkers and Prevention, 27(12), 1450-1461. [More Information]
Lew, J., St John, D., Macrae, F., Emery, J., Ee, H., Jenkins, M., He, E., Grogan, P., Caruana, M., Sarfati, D., Canfell, K., et al (2018). Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia. International Journal of Cancer, 143(2), 269-282. [More Information]
He, E., Lew, J., Egger, S., Banks, E., Ward, R., Beral, V., Canfell, K. (2018). Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort. Preventive Medicine, 106, 185-193. [More Information]
Smith, M., Hall, M., Lew, J., Canfell, K. (2018). Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand. Vaccine, 36(42), 6314-6324. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]

show 2 more

2017

Lew, J., Simms, K., Smith, M., Saville, M., Hammond, I., Canfell, K. (2017). Cost-effectiveness estimates: the need for complete reporting – Authors' reply. The Lancet Public Health, 2(5), e212. [More Information]
Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
Lew, J., St John, D., Xu, X., Greuter, M., Caruana, M., Cenin, D., He, E., Saville, A., Grogan, P., Coupe, V., Canfell, K. (2017). Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: A modelling study. The Lancet Public Health, 2(7), e331-e340. [More Information]
Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]

show 2 more

2016

Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
Greuter, M., Demirel, E., Lew, J., Berkhof, J., Xu, X., Canfell, K., Dekker, E., Meijer, G., Coupé, V. (2016). Long-term impact of the dutch colorectal cancer screening program on cancer incidence and mortality - Model-based exploration of the serrated pathway. Cancer Epidemiology Biomarkers and Prevention, 25(1), 135-144. [More Information]
Greuter, M., Berkhof, J., Canfell, K., Lew, J., Dekker, E., Coupe, V. (2016). Resilience of a FIT screening programme against screening fatigue: a modelling study. BMC Public Health, 16(1), 1-8. [More Information]
Greuter, M., Berkhof, J., Fijneman, R., Demirel, E., Lew, J., Meijer, G., Stoker, J., Cou?e, V. (2016). The potential of imaging techniques as a screening tool for colorectal cancer: A cost-effectiveness analysis. British Journal of Radiology, 89(1063), 20150910. [More Information]
Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]
Simms, K., Smith, M., Lew, J., Kitchener, H., Castle, P., Canfell, K. (2016). Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. International Journal of Cancer, 139(12), 2771-2780. [More Information]

show 5 more

2015

Kang, Y., O'Connell, D., Tan, J., Lew, J., Demers, A., Lotocki, R., Kliewer, E., Hacker, N., Jackson, M., Delaney, G., et al (2015). Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. Cancer Epidemiology, 39(4), 600-611. [More Information]

2014

Greuter, M., Xu, X., Lew, J., Dekker, E., Kuipers, E., Canfell, K., Meijer, G., Coupé, V. (2014). Modeling the adenoma and serrated pathway to colorectal cancer (ASCCA). Risk Analysis, 34(5), 889-910. [More Information]

2012

Walker, R., Nickson, C., Lew, J., Smith, M., Canfell, K. (2012). A revision of sexual mixing matrices in models of sexually transmitted infection. Statistics in Medicine, 31(27), 3419-3432. [More Information]
Legood, R., Smith, M., Lew, J., Walker, R., Moss, S., Kitchener, H., Patnick, J., Canfell, K. (2012). Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ: British Medical Journal, 345, 1-10. [More Information]
Shi, J., Chen, J., Canfell, K., Feng, X., Ma, J., Zhang, Y., Zhao, F., Li, R., Ma, L., Li, Z., et al (2012). Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study. BMC Health Services Research, 12(1), 1-14. [More Information]
Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]
Shi, J., Canfell, K., Lew, J., Qiao, Y. (2012). The burden of cervical cancer in China: Synthesis of the evidence. International Journal of Cancer, 130(3), 641-652. [More Information]

show 2 more

2011

Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]
Canfell, K., Shi, J., Lew, J., Walker, R., Zhoa, F., Simonella, L., Chen, J., Legood, R., Smith, M., Nickson, C., et al (2011). Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Vaccine, 29(13), 2487-2494. [More Information]
Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]

2010

Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]

2008

Beekman, M., Lew, J. (2008). Foraging in honeybees - when does it pay to dance? Behavioral Ecology, 19(2), 255-262. [More Information]
Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]

2006

Ho, J., Adams, C., Lew, J., Matthews, T., Ng, C., Shahabi-Sirjani, A., Tan, L., Zhao, C., Easteal, S., Wilson, S., Jermiin, L. (2006). SeqVis: Visualisation of compositional heterogeneity in large alignments of nucleotides. Bioinformatics, 22(17), 2162-2163. [More Information]

Selected Grants

2022

SMARTERscreen: A randomised controlled trial of patient SMS messaging in general practice to increase participation in the National Bowel Cancer Screening Program, Jenkins M, Lew J, Goodwin B, National Health and Medical Research Council (NHMRC)/Targeted Call for Research into Participation in Cancer Screening Programs 2021

Health Technology assessment reports and commissioned reports

Worthington J, Lew JB, Canfell K, and Feletto E. Modelled analysis of potential hypothetical impacts of COVID-19 related disruptions.on the National Bowel Cancer Screening Program. Report to the Department of Health (May 2020)
Cost-effectiveness of the 2019 NBCSP Mass-Media Campaign (June 2019)
Lew JB, Feletto E, Worthington J, and Canfell K. National Bowel Cancer Screening Program and Aboriginal and Torres Strait Islander peoples: the potential impact on the health outcomes and cost-effectiveness of bowel cancer screening for Aboriginal and Torres Strait Islander peoples in Australia. Report to the South Australia Department for Health and Wellbeing. Sep 2019.
Worthington J, Lew JB, Feletto E, Canfell K. Modelled analysis of NBCSP-related colonoscopy demand by LHD. Report prepared for Cancer Institute of NSW. January 2019.
Worthington J, Lew JB, Feletto E, Canfell K. Modelled impact of increased NBCSP participation on colorectal cancer outcomes, cost and resource utilisation in the NSW population. Report prepared for Cancer Institute of NSW. December 2018.
Worthington J, Lew JB, Feletto E, Canfell K. Modelled comparison of proposed surveillance recommendations for the NBCSP. Report prepared by Cancer Research Division, Cancer Council NSW to support the Clinical practice guidelines for surveillance colonoscopy guidelines. March 2018.
Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Sarfati D, Greuter MJE, Coupé VMH, Canfell K. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia. Report to the 2017 review of the Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Feb 2017
Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Greuter MJE, Coupé VMH, Canfell K. Benefits, harms and costs of potential age-extensions to the National Bowel Cancer Screening Program in Australia.Report to the 2017 review of the Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Feb 2017
Lew JB*and Simms K*, Smith M, Kang YJ, Xu XM, Caruana M, Walker R, Canfell K. National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting. Report to the Medical Services Advisory Committee. Department of Health and Ageing, Australia. June 2014.
Simms K, Lew JB, Caurana M, Walker R, Smith M, Canfell K, Economic modelling of cervical screening with primary HPV testing in England. In: Kitchener HC, Canfell K, Gilham C, Sargent A, Roberts C, Desai M and Peto J on behalf of the ARTISTIC Trial Study Group. ARTISTIC: six year follow-up of a trial of human papillomavirus (HPV) testing and implications for the cost-effectiveness of primary HPV screening in England. Submitted to Health Technology Assessment. April 2014.
Canfell K, Lew JB, Smith M, Walker R. Modelling HPV test of cure. In: Moss S, Kelly R, Legood R, Sadique Z, Canfell K, Lew JB, Smith M, Walker R. Evaluation of Sentinel Sites for HPV Triage and test of cure. Report to the NHS Cancer Screening Programmes (UK). September 2011. (Available at: http://www.cancerscreening.nhs.uk/cervical/sentinelfinalreport.pdf)
Canfell K, Lew JB, Smith M and Walker R. Cost-effectiveness modelling beyond MAVARIC study end-points, in: HC Kitchener, R Blanks, H Cubie, M Desai, G Dunn, R Legood, A Gray, Z Sadique and S Moss, on behalf of the MAVARIC Trial Study Group. MAVARIC – a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. Health Technology Assessment 2011; Vol. 15: No. 3. January 2011. (Available at: http://www.hta.ac.uk/fullmono/mon1503.pdf)
Economic Evaluation of the Impact of HPV Vaccination on Cervical Screening in New Zealand. Report to the New Zealand Ministry of Health National Screening Unit. 2010.
Application 1122: Automation assisted and liquid based cytology for cervical cancer screening. Report to the Medical Services Advisory Committee. Department of Health and Ageing, Australia. March 2009.
Reference 39: Human Papillomavirus Triage Test for Women With Cytological Prediction of Possible or Definite Low-Grade Squamous Intraepithelial Lesions. Report to the Medical Services Advisory Committee. Department of Health and Ageing, Australia. March 2009.

Page not found

Dr Jie-Bin Lew

Publications

By Type

By Year

Selected Grants

2022

Health Technology assessment reports and commissioned reports